Concepedia

Matthew J. Berberich

MJ

13

Publications

714

Citations

11

H-Index

2015

Active since

Affiliations

Harvard University(Current)

Dana-Farber Cancer Institute

Center for Systems Biology

Ragon Institute of MGH, MIT and Harvard

Brigham and Women's Hospital

Matthew J. Berberich is an author at Harvard University specializing in medicine, natural sciences, and molecular biology.

Top concepts

MedicineNatural SciencesMolecular BiologyCell BiologyImmunologyProteomicsBiochemistryImmunotherapyTumor BiologyBioinformatics

Publications per year

2015–2023

13

Publications

13

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

Anita K. Mehta, Emily Cheney, Christina Hartl et al. · Nature Cancer · 2020 · 239 citations · Full text

Breast Oncology, Medicine, Immunology +8

Discovery and resistance mechanism of a selective CDK12 degrader

Baishan Jiang, Yang Gao, Jianwei Che et al. · Nature Chemical Biology · 2021 · 131 citations · Full text

Signal Transduction, Natural Sciences, Receptor Tyrosine Kinase +5

Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome

Suman Rao, Deepak Gurbani, Guangyan Du et al. · Cell chemical biology · 2019 · 65 citations · Full text

Protein Function, Compound Promiscuity, Structural Bioinformatics +11

A dynamic view of the proteomic landscape during differentiation of ReNcell VM cells, an immortalized human neural progenitor line

Yuyu Song, Kartik Subramanian, Matthew J. Berberich et al. · Scientific Data · 2019 · 58 citations · Full text

Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions

Yang Gao, Baishan Jiang, Hellen Kim et al. · Journal of Medicinal Chemistry · 2023 · 37 citations · Full text

Molecular Biology, Catalytic Degraders, Multiple Catalytic Degraders +17

Rows per page

1–5 of 13